![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
June 2007 |
||||||||||||||||||||||||||||||||||||||||||||||||||
TriLink R&D Achievement TriLink Awarded Phase I Grant for a Second Hot Start PCR Project TriLink has been awarded a Small Business Innovation Research (SBIR) Phase I grant. In these studies, TriLink will investigate its second novel approach for Hot Start activation in PCR. This approach, which employs chemically-modified triphosphates to inhibit DNA polymerase activity until a thermal activation step, has already showed significant promise in the reduction of off-target amplification products in PCR. Proposed experimentation includes optimization of the Hot Start effect and further investigation in its benchtop applications. For more information please feel free to contact us. | News & Events
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Technology Spotlight: 2' Fluoro NTPs
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2006 TriLink BioTechnologies, Inc. All rights reserved by the respective owner. OligoBuilder is a registered service mark and the TriLink logo is a trademark of TriLink Biotechnologies, Inc. All other trademarks are covered by their respective owners. |